These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23554313)

  • 1. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
    Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
    J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.
    Chewning JH; Gudme CN; Hsu KC; Selvakumar A; Dupont B
    J Immunol; 2007 Jul; 179(2):854-68. PubMed ID: 17617576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
    Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
    N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
    Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
    Front Immunol; 2019; 10():734. PubMed ID: 31024561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.
    Fauriat C; Ivarsson MA; Ljunggren HG; Malmberg KJ; Michaëlsson J
    Blood; 2010 Feb; 115(6):1166-74. PubMed ID: 19903900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation.
    Hanvesakul R; Kubal C; Moore J; Neil D; Cook M; Ball S; Briggs D; Moss P; Cockwell P
    PLoS One; 2011; 6(8):e23631. PubMed ID: 21912600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.
    Yu J; Venstrom JM; Liu XR; Pring J; Hasan RS; O'Reilly RJ; Hsu KC
    Blood; 2009 Apr; 113(16):3875-84. PubMed ID: 19179302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of KIR2DS1 does not significantly contribute to NK cell cytotoxicity in HLA-C1/C2 heterozygous haplotype B donors.
    Baltner K; Kübler A; Pal M; Balvociute M; Mezger M; Handgretinger R; André MC
    Int Immunol; 2017 Nov; 29(9):423-429. PubMed ID: 29099970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
    Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
    Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.
    Fischer JC; Ottinger H; Ferencik S; Sribar M; Punzel M; Beelen DW; Schwan MA; Grosse-Wilde H; Wernet P; Uhrberg M
    J Immunol; 2007 Mar; 178(6):3918-23. PubMed ID: 17339492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.
    Sivori S; Carlomagno S; Falco M; Romeo E; Moretta L; Moretta A
    Blood; 2011 Apr; 117(16):4284-92. PubMed ID: 21355085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I.
    Moesta AK; Graef T; Abi-Rached L; Older Aguilar AM; Guethlein LA; Parham P
    J Immunol; 2010 Oct; 185(7):4233-7. PubMed ID: 20802150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
    Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
    Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.
    Mancusi A; Ruggeri L; Urbani E; Pierini A; Massei MS; Carotti A; Terenzi A; Falzetti F; Tosti A; Topini F; Bozza S; Romani L; Tognellini R; Stern M; Aversa F; Martelli MF; Velardi A
    Blood; 2015 May; 125(20):3173-82. PubMed ID: 25769621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
    Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.
    Ashouri E; Rajalingam K; Barani S; Farjadian S; Ghaderi A; Rajalingam R
    Sci Rep; 2021 Apr; 11(1):7932. PubMed ID: 33846431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.
    Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O
    J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.